June 16

patent_9037268_585x585_for_blogAfter over five-and-a-half years of R&D and associated efforts, I am proud to say that I have received the patent on my treatment technology for Alzheimer’s Disease:  U.S. Patent 9,037,268

As I mentioned in my statement to the press, I made the decision with my company to forgo patent licensing fees for R&D.  This is too important of an innovation to keep it bottled up or to inhibit the early stages of medical research.  Too many people are suffering. Too many people are dying.

Alzheimer’s Disease is an incurable disease that affects 5.3 million people in the U.S. and nearly 44 million worldwide.

My patented technology is based on years of research by scientists regarding the effects of radio waves on the human brain.  Recent studies exposed RF energy to mice that have been genetically modified to exhibit Alzheimer’s disease.  Mice and humans share 95% of their genes, providing an appropriate reference for comparative studies.

One study in particular was the research conducted by the University of South Florida. (The research study, as published in the Journal of Alzheimer’s Disease, is available at my company’s special Web site www.AlzheimersTreatmentInvention.com.) The following is from the Abstract of the published study: “Although caution should be taken in extrapolating these mouse studies to humans, we conclude that EMF [electromagnetic field / radio frequency energy] exposure may represent a non-invasive, non-pharmacologic therapeutic against Alzheimer’s disease….” The study concludes “… we believe that the current lack of an effective therapeutic against [Alzheimer’s Disease], in concert with this study’s surprising findings, justifies EMF exposure as a non-invasive, non-pharmacologic approach worthy of vigorous investigation.”

For more information, including research references, the patent, the full press announcement, and links to TV, radio, and other media / new reports, please visit www.AlzheimersTreatmentInvention.com.

Please share this post...Share on FacebookShare on Google+Share on LinkedInTweet about this on TwitterEmail this to someone